J&J Beats Profit Estimates on Pharmaceutical, Medtech Sales as COVID-19 Shot Revenue Slows
Johnson & Johnson beat profit and sales estimates and boosted its outlook as pharmaceutical and medical device sales gain while demand for COVID-19 vaccines wanes.
( 1
min )